2024 Sec filing immatics

Sec filing immatics

Author: qdas

August undefined, 2024

Web23 Aug 2024 · The SEC requires all publicly traded companies, foreign and domestic, to disclose financial condition, operating results, management compensation, and other … WebImmatics Announces Third Quarter 2024 Financial Results and Business Update Immatics Announces $110 Million Underwritten Offering of Ordinary Shares Immatics Announces Full Year 2024 Financial Results and Corporate Update Our PIPELINE INVESTORS Our Mission

Immatics N.V. Ordinary Shares (IMTX) SEC Filings Nasdaq

Web21 Mar 2024 · Immatics N.V. (IMTX) SEC Filing 6-K Foreign Issuer Report for the period ending Wednesday, March 22, 2024. Home. SEC Filings. Immatics B.V. (IMTX) ... Immatics B.V. provided additional information to their SEC Filing as exhibits. Exhibit 99.1: Additional Exhibits. Exhibit 99.2: Additional Exhibits. Ticker: IMTX CIK: 1809196 WebOn June 1, 2024, Immatics US, Inc. entered into a License, Development and Commercialization agreement (the “Allogeneic ACT agreement”) with Bristol-Myer … hy vee grocery springfield il

SEC Filing Immatics N.V.

Web3 Jun 2024 · As per the deal, Immatics is eligible to get $60m in upfront payment as well as development, regulatory and commercial milestone payments of up to $700m for each BMS programme. In addition, Immatics will receive tiered royalty payments on net sales of … Web6 Jan 2024 · The Immatics Approach to Disrupt Current Tumor Treatment Paradigms Based on 5 Defined Principals True Cancer Targets & Matching Right TCRs Targeted Approach in … Web15 Jul 2024 · Immatics’ Pipeline Addresses Significant Number of Cancer Patients Prevalence of MAGE4/8, MAGEA1 and PRAME in Major Solid Cancer Indications 9 Niche … hy-vee grocery store cedar falls ia

SEC Filing Immatics N.V.

Webof the Securities Exchange Act of 1934 October 28, 2024 Commission File Number: 001-39363 IMMATICS N.V. Paul-Ehrlich-Straße 15 72076 Tübingen, Federal Republic of Germany (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Webthe timing of meetings with and feedback from regulatory authorities as well as any submission of filings for regulatory approval of Immatics’ programs; the potential … molly shields md san antonioWeb10 May 2024 · Tuebingen, Germany and Houston, Texas, May 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T... molly shiels cnn

"Web4 Apr 2024 · SEC Filings. Date Filing Type Filing Description Download / View. 04/04/2024. SC 13G/A. Amended Statement of Ownership. 03/31/2024. 10-K. Annual Report. 03/31/2024. " - Sec filing immatics

Sec filing immatics

WebImmatics N.V. is a Dutch public limited liability company (naamloze vennootschap) incorporated on March 10, 2024 and the holding company of Immatics Biotechnologies … Web14 Feb 2024 · Immatics N.V. (b) Address of Issuer's Principal Executive Offices Paul-Ehrlich-Strasse 15, Tubingen 72076 Item 2. (a) Name of Person Filing Wellington Management …

Did you know?

Web4 rows · Immatics’ international team, located in Munich and Tuebingen, Germany, as well as in Houston, ... Web7 Mar 2024 · Registration of securities of foreign private issuers pursuant to section 12 (b) or (g) Annual Filings. 0000950170-23-006473.pdf. 0000950170-23-006473.rtf. 0000950170-23-006473.xls. EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML. Feb 14, 2024. SC 13G/A. An amendment to the SC 13G filing.

Web9 Jan 2024 · SEC.gov Filings & Forms Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. WebSEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.

Web23 Mar 2024 · Immatics entered a global licensing agreement with Bristol Myers Squibb to collaborate on clinical development of TCR Bispecific (TCER ®) IMA401 targeting …

Web31 Mar 2024 · Immatics Price Performance. Shares of IMTX stock opened at $7.18 on Thursday. The stock’s fifty day simple moving average is $8.10 and its 200 day simple moving average is $9.34. The firm has a market cap of $547.33 million, a price-to-earnings ratio of 9.70 and a beta of 0.47. Immatics has a one year low of $5.75 and a one year high …

Web9 Jan 2024 · SEC Filing Immatics N.V. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER … molly shifletWeb22 Mar 2024 · Immatics N.V. (IMTX) SEC Filing 20-F Annual Report for the fiscal year ending Saturday, December 31, 2024. Home. SEC Filings. Immatics B.V. (IMTX) 20-F Annual Report Wed Mar 22 2024; SEC Filings. IMTX Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. IMTX Annual Reports. 20-F ... hy-vee grocery store clarinda iaWeb10 Apr 2024 · SEC Filings. Group. Filing year. Items per page. Filing date Form Description Filing Group View; April 10, 2024: SC 13G/A: An amendment to the SC 13G filing. Other. 0000315066-23-002240.pdf. 0000315066-23-002240.rtf. View HTML: March 31, 2024: 8-K: Report of unscheduled material events or corporate event ... hy-vee grocery store clinton iaWeb25 Mar 2024 · Immatics (NASDAQ:IMTX – Get Rating) – Equities researchers at SVB Leerink issued their Q1 2024 EPS estimates for Immatics in a report issued on Tuesday, March 21st.SVB Leerink analyst J. Chang anticipates that the company will post earnings per share of ($0.42) for the quarter. The consensus estimate for Immatics’ current full-year earnings … molly shields dermatologist santa cruzWebUNITED STATES . SECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 . FORM 6-K. REPORT OF FOREIGN PRIVATE ISSUER . Pursuant to Rule 13a-16 or 15d-16. of the Securities Exc molly shields npiWebSEC Filing Immatics N.V. As filed with the Securities and Exchange Commission on October 9, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE … molly shields dermatologyWeb14 Dec 2024 · In November 2024, Immatics filed a Clinical Trial Application with Paul-Ehrlich-Institute (PEI), the German federal regulatory authority, for the development of IMA401. The clinical trial, which is planned to commence in the first half of 2024, is expected to enroll patients across various solid tumor types. molly shields santa cruz